aminoimidazole carboxamide has been researched along with Fetal Growth Restriction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bales, ES; Doyle, AS; Houck, JA; Julian, CG; Lane, SL; Lorca, RA; Moore, LG | 1 |
1 other study(ies) available for aminoimidazole carboxamide and Fetal Growth Restriction
| Article | Year |
|---|---|
AMP-activated protein kinase activator AICAR attenuates hypoxia-induced murine fetal growth restriction in part by improving uterine artery blood flow.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Female; Fetal Growth Retardation; Hypoxia; Mice; Placental Circulation; Pregnancy; Ribonucleotides; Uterine Artery | 2020 |